|
VPS13B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.956010E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.003200E-01 |
| Normal-vs-Stage2 |
3.837600E-01 |
| Normal-vs-Stage3 |
1.563680E-03 |
| Normal-vs-Stage4 |
9.70809999999434E-05 |
| Stage1-vs-Stage2 |
5.899600E-01 |
| Stage1-vs-Stage3 |
4.639200E-03 |
| Stage1-vs-Stage4 |
1.404990E-04 |
| Stage2-vs-Stage3 |
1.634970E-01 |
| Stage2-vs-Stage4 |
5.332400E-02 |
| Stage3-vs-Stage4 |
3.372800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.507700E-02 |
| Normal-vs-AfricanAmerican |
1.075940E-02 |
| Normal-vs-Asian |
8.689200E-01 |
| Caucasian-vs-AfricanAmerican |
3.315200E-01 |
| Caucasian-vs-Asian |
4.742800E-01 |
| AfricanAmerican-vs-Asian |
2.298400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.559200E-04 |
| Normal-vs-Female |
8.808000E-01 |
| Male-vs-Female |
1.615840E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.376700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.209970E-01 |
| Normal-vs-Age(61-80Yrs) |
1.744400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.388200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.682440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.262000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.027000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.500000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.919200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.014400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.779500E-02 |
| Normal-vs-Grade 2 |
5.390600E-01 |
| Normal-vs-Grade 3 |
2.900900E-03 |
| Normal-vs-Grade 4 |
2.16760000004701E-06 |
| Grade 1-vs-Grade 2 |
3.221900E-03 |
| Grade 1-vs-Grade 3 |
3.66929999999765E-05 |
| Grade 1-vs-Grade 4 |
7.421200E-04 |
| Grade 2-vs-Grade 3 |
8.955100E-03 |
| Grade 2-vs-Grade 4 |
4.72480000002218E-06 |
| Grade 3-vs-Grade 4 |
2.944100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.648000E-01 |
| Normal-vs-ccB subtype |
4.10480000000435E-05 |
| ccA subtype-vs-ccB subtype |
6.65660004894875E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.128300E-02 |
| Normal-vs-N1 |
1.729780E-02 |
| N0-vs-N1 |
2.641800E-01 |
|
|
